163 related articles for article (PubMed ID: 25494864)
1. Genetic markers of insulin sensitivity and insulin secretion are associated with spontaneous postnatal growth and response to growth hormone treatment in short SGA children: the North European SGA Study (NESGAS).
Jensen RB; Thankamony A; Day F; Scott RA; Langenberg C; Kirk J; Donaldson M; Ivarsson SA; Söder O; Roche E; Hoey H; Juul A; Ong KK; Dunger DB
J Clin Endocrinol Metab; 2015 Mar; 100(3):E503-7. PubMed ID: 25494864
[TBL] [Abstract][Full Text] [Related]
2. Adiposity in Children Born Small for Gestational Age Is Associated With β-Cell Function, Genetic Variants for Insulin Resistance, and Response to Growth Hormone Treatment.
Thankamony A; Jensen RB; O'Connell SM; Day F; Kirk J; Donaldson M; Ivarsson SA; Söder O; Roche E; Hoey H; Ong KK; Dunger DB; Juul A
J Clin Endocrinol Metab; 2016 Jan; 101(1):131-42. PubMed ID: 26588449
[TBL] [Abstract][Full Text] [Related]
3. The exon3-deleted growth hormone receptor gene polymorphism (d3-GHR) is associated with insulin and spontaneous growth in short SGA children (NESGAS).
Wegmann MG; Thankamony A; Roche E; Hoey H; Kirk J; Shaikh G; Ivarsson SA; Söder O; Dunger DB; Juul A; Jensen RB
Growth Horm IGF Res; 2017 Aug; 35():45-51. PubMed ID: 28719834
[TBL] [Abstract][Full Text] [Related]
4. Baseline IGF-I levels determine insulin secretion and insulin sensitivity during the first year on growth hormone therapy in children born small for gestational age. Results from a North European Multicentre Study (NESGAS).
Jensen RB; Thankamony A; O'Connell SM; Salgin B; Kirk J; Donaldson M; Ivarsson SA; Söder O; Roche E; Hoey H; Dunger DB; Juul A;
Horm Res Paediatr; 2013; 80(1):38-46. PubMed ID: 23860366
[TBL] [Abstract][Full Text] [Related]
5. Insulin sensitivity modulates the growth response during the first year of high-dose growth hormone treatment in short prepubertal children born small for gestational age.
Gies I; Thomas M; Tenoutasse S; De Waele K; Lebrethon MC; Beckers D; Francois I; Maes M; Rooman R; de Beaufort C; Massa G; De Schepper J
Horm Res Paediatr; 2012; 78(1):24-30. PubMed ID: 22832126
[TBL] [Abstract][Full Text] [Related]
6. Interactions between TCF7L2 genotype and growth hormone-induced changes in glucose homeostasis in small for gestational age children.
de Kort SW; Mook-Kanamori DO; Jaddoe VW; Hokken-Koelega AC
Clin Endocrinol (Oxf); 2010 Jan; 72(1):47-52. PubMed ID: 19473183
[TBL] [Abstract][Full Text] [Related]
7. Growth and growth hormone treatment in short stature children born small for gestational age.
Labarta JI; Ruiz JA; Molina I; De Arriba A; Mayayo E; Longás AF
Pediatr Endocrinol Rev; 2009 Feb; 6 Suppl 3():350-7. PubMed ID: 19404234
[TBL] [Abstract][Full Text] [Related]
8. Safety of growth hormone treatment in children born small for gestational age: the US trial and KIGS analysis.
Cutfield WS; Lindberg A; Rapaport R; Wajnrajch MP; Saenger P
Horm Res; 2006; 65 Suppl 3():153-9. PubMed ID: 16612129
[TBL] [Abstract][Full Text] [Related]
9. Growth and metabolic effects of long-term recombinant human growth hormone (rhGH) treatment in short children born small for gestational age: GH-RAST study.
Labarta JI; de Arriba A; Ferrer M; Loranca M; Martos JM; Rodríguez A; Samaniego ML; Sánchez-Cenizo L
J Pediatr Endocrinol Metab; 2020 Jul; 33(7):923-932. PubMed ID: 32623373
[TBL] [Abstract][Full Text] [Related]
10. Growth hormone (GH)-binding protein in prepubertal short children born small for gestational age: effects of growth hormone treatment. Swedish Study Group for Growth Hormone Treatment.
Boguszewski M; Bjarnason R; Rosberg S; Carlsson LM; Albertsson-Wikland K
J Clin Endocrinol Metab; 1997 Apr; 82(4):1014-9. PubMed ID: 9100566
[TBL] [Abstract][Full Text] [Related]
11. Increases in Bioactive IGF do not Parallel Increases in Total IGF-I During Growth Hormone Treatment of Children Born SGA.
Wegmann MG; Jensen RB; Thankamony A; Frystyk J; Roche E; Hoey H; Kirk J; Shaikh G; Ivarsson SA; Söder O; Dunger DB; Juul A
J Clin Endocrinol Metab; 2020 Apr; 105(4):. PubMed ID: 31665326
[TBL] [Abstract][Full Text] [Related]
12. Serum leptin in short children born small for gestational age: relationship with the growth response to growth hormone treatment. The Swedish Study Group for Growth Hormone Treatment.
Boguszewski M; Dahlgren J; Bjarnason R; Rosberg S; Carlsson LM; Carlsson B; Albertsson-Wikland K
Eur J Endocrinol; 1997 Oct; 137(4):387-95. PubMed ID: 9368507
[TBL] [Abstract][Full Text] [Related]
13. Final height data, body composition and glucose metabolism in growth hormone-treated short children born small for gestational age.
Hokken-Koelega AC; van Pareren Y; Sas T; Arends N
Horm Res; 2003; 60 Suppl 3():113-4. PubMed ID: 14671407
[TBL] [Abstract][Full Text] [Related]
14. Methylphenidate and the response to growth hormone treatment in short children born small for gestational age.
Renes JS; de Ridder MA; Breukhoven PE; Lem AJ; Hokken-Koelega AC
PLoS One; 2012; 7(12):e53164. PubMed ID: 23300884
[TBL] [Abstract][Full Text] [Related]
15. Children born small-for-gestational age: postnatal growth and hormonal status.
Albertsson-Wikland K; Boguszewski M; Karlberg J
Horm Res; 1998; 49 Suppl 2():7-13. PubMed ID: 9730665
[TBL] [Abstract][Full Text] [Related]
16. GH responsiveness in a large multinational cohort of SGA children with short stature (NESTEGG) is related to the exon 3 GHR polymorphism.
Tauber M; Ester W; Auriol F; Molinas C; Fauvel J; Caliebe J; Nugent T; Fryklund L; Ranke MB; Savage MO; Clark AJ; Johnston LB; Hokken-Koelega AC;
Clin Endocrinol (Oxf); 2007 Sep; 67(3):457-61. PubMed ID: 17555507
[TBL] [Abstract][Full Text] [Related]
17. Changes in serum insulin-like growth factor I (IGF-I) and IGF-binding protein-3 levels during growth hormone treatment in prepubertal short children born small for gestational age.
Boguszewski M; Jansson C; Rosberg S; Albertsson-Wikland K
J Clin Endocrinol Metab; 1996 Nov; 81(11):3902-8. PubMed ID: 8923836
[TBL] [Abstract][Full Text] [Related]
18. Thyroid function in short children born small-for-gestational age (SGA) before and during GH treatment.
de Kort SW; Willemsen RH; van der Kaay DC; van Dijk M; Visser TJ; Hokken-Koelega AC
Clin Endocrinol (Oxf); 2008 Aug; 69(2):318-22. PubMed ID: 18221400
[TBL] [Abstract][Full Text] [Related]
19. Early, discontinuous, high dose growth hormone treatment to normalize height and weight of short children born small for gestational age: results over 6 years.
de Zegher F; Du Caju MV; Heinrichs C; Maes M; De Schepper J; Craen M; Vanweser K; Malvaux P; Rosenfeld RG
J Clin Endocrinol Metab; 1999 May; 84(5):1558-61. PubMed ID: 10323379
[TBL] [Abstract][Full Text] [Related]
20. First two years' response to growth hormone treatment in very young preterm small for gestational age children.
Garcia RA; Longui CA; Kochi C; Arruda M; Faria CD; Calliari LE; Monte O; Pachi PR; Saenger P
Horm Res; 2009; 72(5):275-80. PubMed ID: 19844113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
